Raymond James Financial Services Advisors Inc. grew its position in Colgate-Palmolive (NYSE:CL – Free Report) by 0.5% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 266,664 shares of the company’s stock after acquiring an additional 1,303 shares during the quarter. Raymond James Financial Services Advisors Inc.’s holdings in Colgate-Palmolive were worth $25,877,000 at the end of the most recent reporting period.
A number of other hedge funds have also modified their holdings of CL. Norges Bank acquired a new position in Colgate-Palmolive in the 4th quarter valued at about $731,843,000. Price T Rowe Associates Inc. MD increased its holdings in shares of Colgate-Palmolive by 27.8% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 41,067,130 shares of the company’s stock valued at $3,698,096,000 after purchasing an additional 8,933,912 shares in the last quarter. Swedbank AB acquired a new stake in shares of Colgate-Palmolive in the first quarter valued at about $286,370,000. Magellan Asset Management Ltd boosted its holdings in Colgate-Palmolive by 4,162.6% during the fourth quarter. Magellan Asset Management Ltd now owns 2,016,290 shares of the company’s stock worth $160,718,000 after buying an additional 1,968,988 shares in the last quarter. Finally, Confluence Investment Management LLC purchased a new position in Colgate-Palmolive in the first quarter valued at about $130,622,000. 80.41% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
Several equities analysts recently weighed in on CL shares. Hsbc Global Res downgraded Colgate-Palmolive from a “strong-buy” rating to a “hold” rating in a research note on Friday, July 26th. HSBC restated a “hold” rating on shares of Colgate-Palmolive in a research report on Friday, July 26th. Jefferies Financial Group downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating and lowered their price objective for the company from $103.00 to $95.00 in a research report on Wednesday, July 24th. BNP Paribas began coverage on Colgate-Palmolive in a research report on Monday, June 24th. They set an “outperform” rating and a $109.00 target price on the stock. Finally, Sanford C. Bernstein upped their price target on shares of Colgate-Palmolive from $100.00 to $103.00 and gave the stock a “market perform” rating in a research report on Tuesday, July 30th. Eight equities research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Colgate-Palmolive presently has a consensus rating of “Moderate Buy” and a consensus target price of $101.11.
Colgate-Palmolive Stock Down 0.1 %
Shares of Colgate-Palmolive stock opened at $101.85 on Tuesday. The company has a market capitalization of $83.56 billion, a PE ratio of 32.23, a P/E/G ratio of 3.54 and a beta of 0.39. Colgate-Palmolive has a 1-year low of $67.62 and a 1-year high of $104.15. The company has a debt-to-equity ratio of 16.90, a current ratio of 1.06 and a quick ratio of 0.28. The business has a 50-day moving average of $98.45 and a 200-day moving average of $92.42.
Colgate-Palmolive (NYSE:CL – Get Free Report) last released its quarterly earnings results on Friday, July 26th. The company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.87 by $0.04. Colgate-Palmolive had a net margin of 14.21% and a return on equity of 470.19%. The business had revenue of $5.06 billion during the quarter, compared to the consensus estimate of $5 billion. During the same quarter last year, the company earned $0.77 earnings per share. The business’s quarterly revenue was up 4.9% compared to the same quarter last year. As a group, equities analysts forecast that Colgate-Palmolive will post 3.57 EPS for the current fiscal year.
Colgate-Palmolive Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Thursday, August 15th. Investors of record on Friday, July 19th were paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 1.96%. The ex-dividend date was Friday, July 19th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 63.29%.
Insiders Place Their Bets
In other news, insider Sally Massey sold 15,850 shares of the firm’s stock in a transaction dated Tuesday, August 6th. The shares were sold at an average price of $103.28, for a total value of $1,636,988.00. Following the transaction, the insider now directly owns 13,942 shares in the company, valued at approximately $1,439,929.76. The transaction was disclosed in a legal filing with the SEC, which is available at this link. In other Colgate-Palmolive news, insider Sally Massey sold 15,850 shares of the stock in a transaction on Tuesday, August 6th. The stock was sold at an average price of $103.28, for a total value of $1,636,988.00. Following the sale, the insider now directly owns 13,942 shares of the company’s stock, valued at $1,439,929.76. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Gregory Malcolm sold 10,533 shares of the business’s stock in a transaction on Tuesday, August 6th. The stock was sold at an average price of $103.10, for a total value of $1,085,952.30. Following the transaction, the executive vice president now owns 10,377 shares of the company’s stock, valued at approximately $1,069,868.70. The disclosure for this sale can be found here. Insiders sold a total of 41,177 shares of company stock valued at $4,245,835 over the last 90 days. 0.34% of the stock is owned by company insiders.
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
See Also
- Five stocks we like better than Colgate-Palmolive
- Trading Stocks: RSI and Why it’s Useful
- Buffett’s Big Bet: Should You Follow Berkshire’s Move on OXY?
- 3 Grocery Stocks That Are Proving They Are Still Essential
- GeoVax Labs: Is This Micro-Cap Biotech Stock a Boom or a Bust?
- Dividend Payout Ratio Calculator
- Mutual Funds vs ETFs: Key Differences
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.